Catalyst Pharmaceutical Partners Inc buy Oppenheimer Holdings Inc.
Start price
06.06.24
/
50%
€14.48
Target price
06.06.25
€26.64
Performance (%)
21.03%
Price
27.09.24
€17.53
Summary
This prediction is currently active. The prediction currently has a performance of 21.03%. This prediction currently runs until 06.06.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | -8.390% | -8.390% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€15.07
27.03.24
27.03.24
€26.80
27.03.25
27.03.25
16.33%
27.09.24
27.09.24
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.09
21.12.23
21.12.23
€27.29
21.12.24
21.12.24
24.38%
27.09.24
27.09.24